These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1976661)

  • 21. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
    Korewicki J; Rajecka A; Pogorzelska H; Madeja G
    Kardiol Pol; 1990; 33(6):365-74. PubMed ID: 2128094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease.
    Münzel T; Heitzer T; Kurz S; Harrison DG; Luhman C; Pape L; Olschewski M; Just H
    J Am Coll Cardiol; 1996 Feb; 27(2):297-303. PubMed ID: 8557897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
    Lefkowitz CA; Moe GW; Armstrong PW
    Am J Cardiol; 1987 Jan; 59(3):59B-63B. PubMed ID: 3101477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
    Korewicki J; Kraska T; Ostrzycki A; Opolski G
    Cor Vasa; 1985; 27(4):251-8. PubMed ID: 3931975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specialized delivery systems for intravenous nitroglycerin. Are they necessary?
    Young JB; Pratt CM; Farmer JA; Luck JC; Fennell WH; Roberts R
    Am J Med; 1984 Jun; 76(6A):27-37. PubMed ID: 6430075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.
    Guazzi MD; Agostoni P; Perego B; Lauri G; Salvioni A; Giraldi F; Matturri M; Guazzi M; Marenzi G
    Br Heart J; 1994 Dec; 72(6):534-9. PubMed ID: 7857735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
    Bodemann T; Langescheid C; Hochrein H
    Z Kardiol; 1989 May; 78(5):328-34. PubMed ID: 2499991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of tolerance to nitroglycerin in the arterial and venous circulation of dogs.
    Goldberg RK; Lee RW; Olajos M; Goldman S
    J Am Coll Cardiol; 1987 Dec; 10(6):1335-41. PubMed ID: 3119688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
    Chien YW; Trippodo NC; Frohlich ED
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
    Tsutamoto T; Kinoshita M; Ohbayashi Y; Wada A; Maeda Y; Adachi T
    Circulation; 1994 Aug; 90(2):823-9. PubMed ID: 8044954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.
    Winniford MD; Kennedy PL; Wells PJ; Hillis LD
    Circulation; 1986 Jan; 73(1):138-42. PubMed ID: 3079676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
    Bauer JA; Fung HL
    J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
    Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
    Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intravenous nitroglycerin on hemodynamics in neonates with refractory congestive heart failure or PFC.
    Tamura M; Kawano T
    Acta Paediatr Jpn; 1990 Jun; 32(3):291-8. PubMed ID: 2122634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.